Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium leprae | Probable 4-aminobutyrate aminotransferase GabT (GAMMA-AMINO-N-BUTYRATE TRANSAMINASE) (GABA TRANSAMINASE) (GLUTAMATE:SUCCINIC SEM | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 437 aa | 397 aa | 28.5 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | 4-aminobutyrate aminotransferase | 0.0026 | 0.0937 | 0.0211 |
Mycobacterium ulcerans | hypothetical protein | 0.0184 | 1 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0023 | 0.0742 | 0.5 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0023 | 0.0742 | 0.7919 |
Mycobacterium ulcerans | 4-aminobutyrate aminotransferase | 0.0026 | 0.0937 | 0.0211 |
Brugia malayi | 4-aminobutyrate aminotransferase, mitochondrial precursor | 0.0026 | 0.0937 | 0.1211 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0026 | 0.0937 | 1 |
Wolbachia endosymbiont of Brugia malayi | acetylornithine transaminase protein | 0.0026 | 0.0937 | 1 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0023 | 0.0742 | 0.5 |
Echinococcus granulosus | ornithine aminotransferase | 0.0026 | 0.0937 | 1 |
Plasmodium vivax | ornithine aminotransferase, putative | 0.0026 | 0.0937 | 1 |
Mycobacterium ulcerans | ornithine aminotransferase RocD1 and RocD2 | 0.0026 | 0.0937 | 0.0211 |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.0184 | 1 | 1 |
Plasmodium falciparum | ornithine aminotransferase | 0.0026 | 0.0937 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.7732 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0023 | 0.0742 | 0.7919 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.0184 | 1 | 1 |
Mycobacterium tuberculosis | Probable ornithine aminotransferase (N-terminus part) RocD1 (ornithine--oxo-acid aminotransferase) | 0.0026 | 0.0937 | 0.0211 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.0184 | 1 | 1 |
Mycobacterium tuberculosis | Probable acetylornithine aminotransferase ArgD | 0.0026 | 0.0937 | 0.0211 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0023 | 0.0742 | 0.0959 |
Echinococcus granulosus | Aminotransferase class III | 0.0026 | 0.0937 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0023 | 0.0742 | 0.5 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0023 | 0.0742 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.7732 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0023 | 0.0742 | 0.7919 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0023 | 0.0742 | 0.5 |
Echinococcus multilocularis | Aminotransferase class III | 0.0026 | 0.0937 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0023 | 0.0742 | 0.5 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0023 | 0.0742 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.7732 | 1 |
Schistosoma mansoni | ornithine--oxo-acid transaminase | 0.0026 | 0.0937 | 1 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0026 | 0.0937 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0023 | 0.0742 | 0.7919 |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.0184 | 1 | 1 |
Mycobacterium ulcerans | glutamate-1-semialdehyde aminotransferase | 0.0026 | 0.0937 | 0.0211 |
Toxoplasma gondii | ornithine aminotransferase, mitochondrial precursor, putative | 0.0026 | 0.0937 | 1 |
Mycobacterium ulcerans | acetylornithine aminotransferase | 0.0026 | 0.0937 | 0.0211 |
Chlamydia trachomatis | glutamate-1-semialdehyde-2,1-aminomutase | 0.0026 | 0.0937 | 0.5 |
Mycobacterium ulcerans | L-lysine aminotransferase | 0.0026 | 0.0937 | 0.0211 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0023 | 0.0742 | 0.0959 |
Mycobacterium tuberculosis | Probable L-lysine-epsilon aminotransferase Lat (L-lysine aminotransferase) (lysine 6-aminotransferase) | 0.0026 | 0.0937 | 0.0211 |
Mycobacterium tuberculosis | Probable glutamate-1-semialdehyde 2,1-aminomutase HemL (GSA) (glutamate-1-semialdehyde aminotransferase) (GSA-at) | 0.0026 | 0.0937 | 0.0211 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | 4.73 uM | PubChem BioAssay. Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.6234 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 8.4368 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.